Lingwood C A, Ng A, Hakomori S
Proc Natl Acad Sci U S A. 1978 Dec;75(12):6049-53. doi: 10.1073/pnas.75.12.6049.
Monovalent antibodies (Fab) directed to two classes of transformation-sensitive cell surface components, ganglioside and galactoprotein a (Gap a), inhibit the process of oncogenic viral transformation of cells. Mouse 3T3 cells infected with murine sarcoma virus were not transformed in terms of morphology change and enhancement of sugar uptake when the infected cells were cultured in the presence of monovalent antibodies directed to GM(1) ganglioside or to Gap a. Transformation inhibitory activity of these cell surface ligands was not related to cell growth inhibition because the monovalent antibodies to globoside and divalent Con A were growth inhibitory but did not inhibit oncogenic transformation. Neither anti-GM(1) Fab nor anti-Gap a Fab inhibited virus production. The transformation inhibitory activity of antiganglioside and anti-Gap a Fab was additionally assessed by inhibiting the transformed phenotype in NRK cell lines with mutants of avian sarcoma virus that are temperature sensitive for expression of the transformation phenotype (NRK/LA25). In this cell line, the GM(3) ganglioside (not GM(1)) and Gap a were transformation-sensitive cell surface components. The expression at permissive temperature of transformed phenotypes, such as morphology change and capability of growth in 0.3% agar, was inhibited by preincubation of the cells with anti-GM(3) Fab or anti-Gap a Fab.GM(3) labeling of NRK/LA25 cells decreased at permissive temperature, whereas preincubation of cells with anti-Gap a, which induces the inhibition of transformation after a temperature shift, prevented the decline of GM(3) label on the cell surface. The data suggest a possible correlation between GM(3) and Gap a expression. Application of monovalent antibodies to these transformation-sensitive components may prevent changes of these components on cell surfaces, and thus may result in abortion of phenotypic expression of transformation, although the transforming gene (src) has been set active. These results indicate that pericellular structures influence gene expression.
针对两类对转化敏感的细胞表面成分(神经节苷脂和半乳糖蛋白a,即Gap a)的单价抗体(Fab)可抑制细胞的致癌病毒转化过程。当感染鼠肉瘤病毒的小鼠3T3细胞在针对GM(1)神经节苷脂或Gap a的单价抗体存在下培养时,就形态变化和糖摄取增强而言,这些感染细胞未发生转化。这些细胞表面配体的转化抑制活性与细胞生长抑制无关,因为针对球苷脂的单价抗体和二价伴刀豆球蛋白A具有生长抑制作用,但不抑制致癌转化。抗GM(1) Fab和抗Gap a Fab均不抑制病毒产生。通过用对转化表型表达温度敏感的禽肉瘤病毒突变体抑制NRK细胞系中的转化表型,进一步评估了抗神经节苷脂和抗Gap a Fab的转化抑制活性(NRK/LA25)。在该细胞系中,GM(3)神经节苷脂(而非GM(1))和Gap a是对转化敏感的细胞表面成分。用抗GM(3) Fab或抗Gap a Fab预孵育细胞可抑制在允许温度下转化表型的表达,如形态变化和在0.3%琼脂中生长的能力。NRK/LA25细胞在允许温度下的GM(3)标记减少,而用抗Gap a预孵育细胞(在温度转变后诱导转化抑制)可防止细胞表面GM(3)标记的下降。数据表明GM(3)与Gap a表达之间可能存在相关性。尽管转化基因(src)已被激活,但将单价抗体应用于这些对转化敏感的成分可能会阻止这些成分在细胞表面的变化,从而可能导致转化表型表达的中止。这些结果表明细胞周围结构会影响基因表达。